![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4745 | |
A61K 31/454 | |||
A61K 31/519 | |||
A61K 31/573 | |||
A61K 31/664 | |||
A61K 31/704 | |||
A61P 43/00 | |||
A61P 35/00 | |||
A61K 45/06 | |||
A61K 31/44 | |||
A61K 31/506 | |||
A61K 31/5377 | |||
A61P 35/02 |
(11) | Number of the document | 3325014 |
(13) | Kind of document | T |
(96) | European patent application number | 16744650.9 |
Date of filing the European patent application | 2016-07-19 | |
(97) | Date of publication of the European application | 2018-05-30 |
(45) | Date of publication and mention of the grant of the patent | 2021-05-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/042905 |
Date | 2016-07-19 |
(87) | Number | WO 2017/015262 |
Date | 2017-01-26 |
(30) | Number | Date | Country code |
201562194367 P | 2015-07-20 | US |
(72) |
LICHENSTEIN, Henri, US
ROTHBERG, Jonathan, M., US
GAYLE, Sophia, US
BEEHARRY, Neil, US
BECKETT, Paul, US
LANDRETTE, Sean, US
CONRAD, Chris, US
XU, Tian, US
|
(73) |
AI Therapeutics, Inc.,
530 Old Whitfield Street, Guilford CT 06437,
US
|
(54) | METHODS FOR TREATING CANCER USING APILIMOD |
METHODS FOR TREATING CANCER USING APILIMOD |